InvestorsHub Logo

Millstone

08/17/16 3:58 PM

#5780 RE: BiotechValues #5779

Sure, I guess somebody that bought stock a year ago, never sold, and never averaged down.

I argue that Amedica is a great buy at .65.

I cannot argue on behalf of an investor who purchased stock at $9.60.